Death due to haemorrhage (bleeding) is a preventable death. Yet it accounts for 30% of trauma casualty deaths in a civilian setting, while in a military setting, it accounts for 90% of casualty deaths with potentially survivable injuries. This project will specifically target this clinical need, through the design, construction and evaluation of new innovative products employing potent snake venom proteins to bring about rapid and stable blood clot formation in combination with biomaterials to target specific wound types.

Recent work can be found, Adv Healthc Mater., 2022, DOI: 10.1002/adhm.202200574

  Are you interested in a PhD at the AIBN? Click here, and start your journey today. 

Related sources

Funding boost brings life-saving 'venom' gel device a step closer

Deadly snakes could save your life


biochemistry, snake venom, hydrogel, biomaterials, biomedical research,

Supervisor name/s

Professor Alan Rowan
AIBN Institute Director
Rowan Group

Dr Amanda Kijas
Senior Research Fellow
Rowan Group

Supervisor email/s